Four key factors can greatly impact how much weight people lose while taking GLP-1 drugs like Ozempic, Wegovy, Victoza, and ...

The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...

"Weight loss medications are not one size fits all and patients should always discuss options with a trusted medical professional," one expert told Newsweek.

Long-term weight loss for patients with obesity proved mostly successful after taking prescription-only injectable ...

Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

Jared Holz thought about taking one of the new GLP-1 drugs for weight loss for months before he actually filled the prescription. And even when he got the drug, he waited a month before using it.

The weight-loss market is heating up as a number of companies are looking for a way to upend the dominance of market leaders Novo Nordisk (NVO) and Eli Lilly (LLY) by introducing GLP-1 pills.

FROM LOS ANGELES to London, weight-loss drugs such as Ozempic are reshaping culture as much as waistlines. Some Ozempic-takers have tiny appetites and dine at unusual hours to avoid spells of nausea.

A survey of U.S. adults has found that 25 percent of respondents would consider using weight loss drugs such as Ozempic, Wegovy or Mounjaro without consulting their doctor first. "A patient could ...

Weight loss refers to a decrease in your overall body weight from muscle, water, and fat losses. Fat loss refers to weight loss from fat, and it’s a more specific and healthy goal than general ...

However, the research found that exercising helped preserve bone loss. Experts said that the findings may apply to other ...

Ozempic maker Novo Nordisk (NVO) announced mixed results today for a phase 2 trial of an experimental weight loss pill that ...